Cite
MLA Citation
C. Becherini et al.. “PO-1096 Safety of concurrent TDM-1 and radiotherapy for patients with residual HER2-positive breast cancer.” Radiotherapy and oncology, vol. 161, n.d., pp. S912–S913. http://access.bl.uk/ark:/81055/vdc_100144485880.0x000042